John C. VanRens

536 total citations
14 papers, 335 citations indexed

About

John C. VanRens is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, John C. VanRens has authored 14 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 10 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in John C. VanRens's work include Synthesis and biological activity (9 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Quinazolinone synthesis and applications (4 papers). John C. VanRens is often cited by papers focused on Synthesis and biological activity (9 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Quinazolinone synthesis and applications (4 papers). John C. VanRens collaborates with scholars based in United States. John C. VanRens's co-authors include Biswanath De, Lily C. Hsieh, Michael J. Janusz, Matthew J. Laufersweiler, Adam Gołȩbiowski, Todd A. Brugel, M. Sabat, Michael P. Clark, Roger G. Bookland and Marlene Mekel and has published in prestigious journals such as Bioorganic & Medicinal Chemistry Letters and Heterocycles.

In The Last Decade

John C. VanRens

14 papers receiving 319 citations

Peers

Countries citing papers authored by John C. VanRens

Since Specialization

Citations

This map shows the geographic impact of John C. VanRens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. VanRens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. VanRens more than expected).

Fields of papers citing papers by John C. VanRens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. VanRens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. VanRens. The network helps show where John C. VanRens may publish in the future.

Co-authorship network of co-authors of John C. VanRens

This figure shows the co-authorship network connecting the top 25 collaborators of John C. VanRens. A scholar is included among the top collaborators of John C. VanRens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. VanRens. John C. VanRens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Development of N-4,6-pyrimidine-N-alkyl-N′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer A. Maier, Todd A. Brugel, M. Sabat, Adam Gołȩbiowski, Matthew J. Laufersweiler, John C. VanRens, Corey R. Hopkins, Biswanath De, Lily C. Hsieh, Kimberly K. Brown, (unknown), Michael J. Janusz	12
2	The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck) 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Matthew J. Laufersweiler, Todd A. Brugel, Jennifer Maier, Adam Gołȩbiowski, Biswanath De, (unknown), Lily C. Hsieh, Richard L. Walter, Marlene Mekel, A.G. Evdokimov, Michael J. Janusz	57
3	The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Michael P. Clark, Todd A. Brugel, Jennifer Maier, Roger G. Bookland, Matthew J. Laufersweiler, (unknown), Adam Gołȩbiowski, Biswanath De, Lily C. Hsieh, Richard L. Walter, Marlene Mekel, Michael J. Janusz	11
4	Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd A. Brugel, Jennifer A. Maier, Michael P. Clark, M. Sabat, Adam Gołȩbiowski, Roger G. Bookland, Matthew J. Laufersweiler, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, Marlene Mekel, Michael J. Janusz	15
5	Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Clark, Kelly M. George, Roger G. Bookland, Jack Chen, (unknown), Kumar Thakur, Wenlin Lee, (unknown), (unknown), Todd A. Brugel, John C. VanRens, Matthew J. Laufersweiler, Jennifer A. Maier, M. Sabat, Adam Gołȩbiowski, (unknown), (unknown), Biswanath De, George Zhang	50
6	The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck) 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Todd A. Brugel, Jennifer Maier, Matthew J. Laufersweiler, Adam Gołȩbiowski, Biswanath De, (unknown), Lily C. Hsieh, (unknown), (unknown), Eric G. Suchanek, Michael J. Janusz	18
7	Development of N-2,4-pyrimidine-N-phenyl-N′-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 2 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer A. Maier, Todd A. Brugel, Michael P. Clark, M. Sabat, Adam Gołȩbiowski, Roger G. Bookland, Matthew J. Laufersweiler, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, Kimberly K. Brown, (unknown), Richard L. Walter, Michael J. Janusz	7
8	Synthesis of Novel Pyrimido[4,5-c]pyridazines and 1,2-Dihydro-3a,7,9,9b-Tetraaza-cyclopenta[a]naphthalen-3-ones as Potent Inhibitors of Lymphocyte Specific Kinase (LCK) 2006 ·Heterocycles ·M. Sabat, John C. VanRens, Todd A. Brugel, Jennifer Maier, Matthew J. Laufersweiler, Adam Gołȩbiowski, (unknown), Biswanath De	1
9	The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-α) production 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Michael P. Clark, (unknown), Adam Gołȩbiowski, Todd A. Brugel, M. Sabat, Roger G. Bookland, Matthew J. Laufersweiler, John C. VanRens, (unknown), Biswanath De, Lily C. Hsieh, (unknown), Richard L. Walter, Marlene Mekel, Michael J. Janusz	49
10	The development of monocyclic pyrazolone based cytokine synthesis inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Adam Gołȩbiowski, (unknown), Matthew J. Laufersweiler, Todd A. Brugel, Michael P. Clark, Cynthia M. Clark, (unknown), (unknown), M. Sabat, Roger G. Bookland, John C. VanRens, Biswanath De, Lily C. Hsieh, Michael J. Janusz, Richard L. Walter, (unknown), Marlene Mekel	20
11	The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones 2004 ·Bioorganic & Medicinal Chemistry Letters ·Matthew J. Laufersweiler, Todd A. Brugel, Michael P. Clark, Adam Gołȩbiowski, Roger G. Bookland, (unknown), M. Sabat, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, S.A. Heitmeyer, (unknown), Kimberly K. Brown, Marlene Mekel, Richard L. Walter, Michael J. Janusz	17
12	The development of new bicyclic pyrazole-based cytokine synthesis inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Adam Gołȩbiowski, Michael P. Clark, Matthew J. Laufersweiler, Todd A. Brugel, M. Sabat, Roger G. Bookland, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, (unknown), Michael J. Janusz, Richard L. Walter	17
13	The development of new triazole based inhibitors of tumor necrosis factor-α (TNF-α) production 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), John C. VanRens, Michael G. Natchus, Michael P. Clark, Biswanath De, Lily C. Hsieh, Michael J. Janusz	44
14	The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Matthew J. Laufersweiler, John C. VanRens, Michael G. Natchus, Roger G. Bookland, Neil G. Almstead, Stanisław Pikul, Biswanath De, Lily C. Hsieh, Michael J. Janusz, (unknown), Sean Peng, (unknown), Tomáš Hudlický, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact